Burger Nils, Fraser Douglas, Maritz Martina Alice, Faulkner Janice, Rey Helene
Develco Pharma Schweiz AG, Pratteln, Switzerland.
BioPharma Services Inc., Toronto, Ontario, Canada.
Clin Transl Sci. 2020 May;13(3):539-546. doi: 10.1111/cts.12737. Epub 2020 Feb 7.
The objective of this study was to determine the effect of concomitant alcohol intake on the bioavailability of oxycodone from an oxycodone once-daily (OOD) formulation and an oxycodone twice-daily (OTD) formulation. A phase I, open-label, randomized, crossover alcohol interaction study in 20 healthy volunteers under fasting conditions was conducted. Participants received five treatments, OOD with 240 mL of 0%, 20%, or 40% alcohol; and OTD with 240 mL of 0% or 40% alcohol. Pharmacokinetic parameters did not differ between participants taking OOD with water or with 240 mL of 20% alcohol. There was a slight increase in overall oxycodone absorption from OOD with 40% alcohol but no increase in peak absorption. Oxycodone absorption from OTD showed peak and overall increases with 40% alcohol but maintained a prolonged-release profile. Although it is recommended that alcohol be avoided while taking opioids, there was no evidence of alcohol-induced dose dumping in these oxycodone formulations.
本研究的目的是确定同时摄入酒精对羟考酮每日一次(OOD)制剂和羟考酮每日两次(OTD)制剂中羟考酮生物利用度的影响。在20名健康志愿者中进行了一项空腹条件下的I期开放标签随机交叉酒精相互作用研究。参与者接受了五种治疗,即服用含240毫升0%、20%或40%酒精的OOD制剂,以及服用含240毫升0%或40%酒精的OTD制剂。服用OOD制剂并同时饮用240毫升水或20%酒精的参与者之间的药代动力学参数没有差异。服用含40%酒精的OOD制剂时,羟考酮的总体吸收略有增加,但峰值吸收没有增加。服用含40%酒精的OTD制剂时,羟考酮的吸收在峰值和总体上均有所增加,但仍保持缓释特性。尽管建议在服用阿片类药物时避免饮酒,但在这些羟考酮制剂中没有证据表明酒精会导致剂量倾泻。